BACKGROUND: There is increasing evidence for the presence of oxidative stress and vitamin C deficiency in dialysis patients. Limited data, however, are available regarding the effects of vitamin C supplementation on oxidative stress and inflammation markers in such patients. METHODS: We ran a prospective, randomized, open-label trial to assess the effects of oral vitamin C supplementation (250 mg three times per week) for 2 months on well-defined oxidative and inflammatory markers in 33 chronic haemodialysis (HD) patients. RESULTS: Normalization of plasma total vitamin C and ascorbate levels by oral vitamin C supplementation did not modify plasma levels of carbonyls, C-reactive protein and albumin, or erythrocyte concentrations of reduced and oxidized glutathione. CONCLUSION: Short-term oral vitamin C supplementation did not modify well-defined oxidative/antioxidative stress and inflammation markers in HD patients. Whether a higher oral dose or the intravenous route can modify these markers remains to be determined.
RCT Entities:
BACKGROUND: There is increasing evidence for the presence of oxidative stress and vitamin C deficiency in dialysis patients. Limited data, however, are available regarding the effects of vitamin C supplementation on oxidative stress and inflammation markers in such patients. METHODS: We ran a prospective, randomized, open-label trial to assess the effects of oral vitamin C supplementation (250 mg three times per week) for 2 months on well-defined oxidative and inflammatory markers in 33 chronic haemodialysis (HD) patients. RESULTS: Normalization of plasma total vitamin C and ascorbate levels by oral vitamin C supplementation did not modify plasma levels of carbonyls, C-reactive protein and albumin, or erythrocyte concentrations of reduced and oxidized glutathione. CONCLUSION: Short-term oral vitamin C supplementation did not modify well-defined oxidative/antioxidative stress and inflammation markers in HDpatients. Whether a higher oral dose or the intravenous route can modify these markers remains to be determined.
Authors: Jennifer J DuPont; Meghan G Ramick; William B Farquhar; Raymond R Townsend; David G Edwards Journal: Am J Physiol Renal Physiol Date: 2014-04-23
Authors: Mark G O'Doherty; Sarah E C M Gilchrist; Ian S Young; Michelle C McKinley; John W G Yarnell; K Fred Gey; Alun Evans; Paula M L Skidmore; Jayne V Woodside Journal: Eur J Nutr Date: 2010-04-18 Impact factor: 5.614
Authors: Gladys Block; Christopher D Jensen; Tapashi B Dalvi; Edward P Norkus; Mark Hudes; Patricia B Crawford; Nina Holland; Ellen B Fung; Laurie Schumacher; Paul Harmatz Journal: Free Radic Biol Med Date: 2008-10-10 Impact factor: 7.376
Authors: Charlene Cavalheiro de Menezes; Aracélli Gnatta Dorneles; Rita Leal Sperotto; Marta Medeiros Frescura Duarte; Maria Rosa Chitolina Schetinger; Vania Lúcia Loro Journal: Neurochem Res Date: 2009-02-11 Impact factor: 3.996
Authors: Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud Journal: Cochrane Database Syst Rev Date: 2012-03-14